Markus Frederic Renschler
Impact in
- Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
-
- Brain Metastases and Treatment
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Photodynamic Therapy Research Studies
- Cancer-related cognitive impairment studies
Papers in
-
- Brain Metastases and Treatment 17
- Lung Cancer Diagnosis and Treatment 2
- Photodynamic Therapy Research Studies 2
- Lung Cancer Treatments and Mutations 1
- Oncology 12
- Pancreatic and Hepatic Oncology Research 5
- Lung Cancer Research Studies 5
- Co-authors
- Minesh P. Mehta (16 shared papers)Søren Møller Bentzen (3 shared papers)Mark A. Socinski (9 shared papers)Richard A. Miller (7 shared papers)Vera Hirsh (10 shared papers)Isamu Okamoto (4 shared papers)Jeremy K. Hon (4 shared papers)Jing Li (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (17 papers)Journal of Clinical Oncology (9 papers)Annals of Oncology (4 papers)New England Journal of Medicine (3 papers)Clinical Lung Cancer (2 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Markus Frederic Renschler
60 papers receiving 9.3k citations
Markus Frederic Renschler's Hit Papers
Peers
Comparison fields: 5 of 91
- Oncology 4.4k
- Pulmonary and Respiratory Medicine 1.9k
- Drug Discovery 4
- Biomaterials 337
- Genetics 120
Countries citing papers authored by Markus Frederic Renschler
This map shows the geographic impact of Markus Frederic Renschler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Frederic Renschler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Frederic Renschler more than expected).
Fields of papers citing papers by Markus Frederic Renschler
This network shows the impact of papers produced by Markus Frederic Renschler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Frederic Renschler. The network helps show where Markus Frederic Renschler may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Frederic Renschler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine Hit paper breakdown → | 2013 | 5386 |
| 2 | Weekly nab -Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial Hit paper breakdown → | 2012 | 646 |
| 3 | 2003 | 500 | |
| 4 | 2003 | 392 | |
| 5 | 2007 | 284 | |
| 6 | 2014 | 273 | |
| 7 | 2008 | 239 | |
| 8 | 2004 | 207 | |
| 9 | 2008 | 143 | |
| 10 | 2010 | 139 | |
| 11 | 2002 | 133 | |
| 12 | 2001 | 112 | |
| 13 | 2010 | 101 | |
| 14 | A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging. | 1999 | 99 |
| 15 | 1999 | 98 | |
| 16 | 2012 | 98 | |
| 17 | 2000 | 78 | |
| 18 | 2015 | 72 | |
| 19 | 1999 | 67 | |
| 20 | 2003 | 65 |
About Markus Frederic Renschler
Markus Frederic Renschler is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Infectious Diseases, Statistics and Probability and Cardiology and Cardiovascular Medicine, having authored 60 papers that have together received 9.6k indexed citations. Recurring topics across this work include Brain Metastases and Treatment (17 papers), Pancreatic and Hepatic Oncology Research (5 papers), Lung Cancer Research Studies (5 papers), Lung Cancer Diagnosis and Treatment (2 papers), Infection Control in Healthcare (2 papers), Photodynamic Therapy Research Studies (2 papers), Lung Cancer Treatments and Mutations (1 paper) and Chemotherapy-induced cardiotoxicity and mitigation (1 paper). The work is most often cited by research in Oncology (4.4k citations), Pulmonary and Respiratory Medicine (1.9k citations), Drug Discovery (4 citations), Biomaterials (337 citations) and Genetics (120 citations). Markus Frederic Renschler has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Minesh P. Mehta, Søren Møller Bentzen, Mark A. Socinski, Richard A. Miller, Vera Hirsh, Isamu Okamoto, Jeremy K. Hon, Jing Li, Jennifer Ann Smith and Walter John Curran. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Annals of Oncology, New England Journal of Medicine and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.